Three medical societies claim recent studies have overestimated the potential harms from lung cancer screening and may be deterring patients. Not everyone agrees.
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...
It can be surprising to learn that lung cancer can develop in people who have never smoked. In fact, up to 20% of lung ...
February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...
Five-year survival rates are among the lowest of all cancers, at about 25%. But when caught early enough – through annual CT ...
In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
I read your column every day. In a recent column. you wrote: "Since age is the major risk factor in getting cancer, it is likely that some ...
MedPage Today on MSN
COVID, Then Lung Cancer; Revisiting Nuclear Power and Cancer; Anti-Tumor Cherries?
News, features, and commentary about cancer-related issues ...
Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC ...
Analysis of Large Language Model Decision Making in Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer Data were collected from patients diagnosed between ...
The past 30 years have seen tremendous progress in our fundamental understanding of lung cancer and the development of new treatment strategies,” senior researcher Dr. Cary Gross, a professor at Yale ...
Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results